Mark Tait, MD
Orthopaedic Surgery · Little Rock, ARNPI 1790003499
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,322 of the $2,909 with a category attached, or 79.8%. Midsouth Orthopedics Inc. accounts for 79.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,378 and has fallen 93.2% since, to $162 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in AR, where the typical reported total is $2,620.
Across 10 payments — averaging $290.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Midsouth Orthopedics Inc.$2K
- Axogen$307
- Integra Lifesciences Corporation$116
- Acumed LLC$101
- Checkpoint Surgical, Inc$51
- Exsomed Corporation$13
What the payments were for
- Food & beverage$58720%
- Education$2,32280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Midsouth Orthopedics Inc. | 1 | $2,322 |
| Axogen | 4 | $307 |
| Integra Lifesciences Corporation | 1 | $116 |
| Acumed LLC | 2 | $101 |
| Checkpoint Surgical, Inc | 1 | $51 |
| Exsomed Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TENOGLIDE$116
How this compares
$2,909 in reported general payments places this provider in the 50th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $310 |
| Meloxicam | 15 | $128 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Little Rock
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason SmithLittle Rock$102K
- Richard McCarthyLittle Rock$75K
- Jacob TauntonLittle Rock$62K
- Jeffrey ReeseLittle Rock$59K
- Justin RabinowitzLittle Rock$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.